ASHLEIGH ARROWOOD: Open Payments
NPI 1477228195 · DUBLIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 19 payments from 10 companies in 2025. Trend: 2023 $20 · 2024 $49 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $92 |
| Supernus Pharmaceuticals, Inc. | 4 | $74 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 2 | $38 |
| Corium, LLC | 1 | $27 |
| Lundbeck LLC | 1 | $18 |
| ABBVIE INC. | 1 | $15 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $15 |
Products named: Qelbree, HETLIOZ, Auvelity, CAPLYTA, Jornay PM, INGREZZA, FANAPT, Azstarys.
Industry payments across OH — which companies pay providers there.
